KE Holdings Inc.
16.87USD
-0.4000 (-2.32%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.7▲ | $1.65 | 2 | 1 |
| Next quarter | $1.75▲ | $1.62 | 2 | 2 |
| Current year | $7.57▲ | $6.67 | 12 | 0 |
| Next year | $8.38▲ | $7.64 | 14 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.12 | $2.85 | +0.73 (+34.5%) |
| 2026-03-31 | $0.91 | $1.42 | +0.51 (+55.4%) |
| 2025-12-31 | $0.74 | $0.46 | -0.28 (-37.5%) |
| 2025-09-30 | $1.1 | $1.12 | +0.02 (+1.5%) |
41 ratings from 13 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| CLSA | Initiated | Outperform | $23.8 | Aug 19, 2026 |
| Barclays | Maintained | Overweight | $23 $26 | May 21, 2026 |
| Barclays | Maintained | Overweight | $33 $25 | Aug 15, 2025 |
| JP Morgan | Maintained | Overweight | $24 $22 | Aug 12, 2025 |
| Citigroup | Maintained | Buy | $25.8 $24.8 | May 16, 2025 |
| UBS | Upgraded from Neutral | Buy | $22.1 $23 | May 16, 2025 |
| UBS | Downgraded from Buy | Neutral | $24.5 | Mar 20, 2025 |
| Morgan Stanley | Maintained | Overweight | $19 $27 | Mar 19, 2025 |
| Barclays | Maintained | Overweight | $30 $33 | Nov 25, 2024 |
| B of A Securities | Upgraded from Neutral | Buy | $24 $28 | Oct 30, 2024 |
| B of A Securities | Maintained | Neutral | $21 $24 | Oct 9, 2024 |
| Barclays | Maintained | Overweight | $28 $30 | May 29, 2024 |
| Citigroup | Maintained | Buy | $21.1 | Mar 19, 2024 |
| HSBC | Maintained | Buy | $23.9 $21.8 | Mar 15, 2024 |
| New Street Research | Initiated | Buy | $22 | May 9, 2023 |
| JP Morgan | Maintained | Overweight | $23 $23.5 | Apr 10, 2023 |
| Barclays | Maintained | Overweight | $27 $28 | Mar 30, 2023 |
| JP Morgan | Upgraded from Neutral | Overweight | $17 $23 | Jan 12, 2023 |
| JP Morgan | Maintained | Neutral | $15 $17 | Dec 6, 2022 |
| Barclays | Maintained | Overweight | $26 $27 | Oct 28, 2022 |
| Barclays | Maintained | Overweight | $24 $26 | Aug 25, 2022 |
| HSBC | Upgraded from Hold | Buy | $13.7 $20.8 | Jun 23, 2022 |
| Citigroup | Initiated | Buy | $22.5 | Jun 21, 2022 |
| JP Morgan | Upgraded from Underweight | Neutral | $7.5 $13.5 | May 16, 2022 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $23 $16 | Mar 16, 2022 |
9 filings from 3 insiders · 0 buy / 0 sell over 6m
Officers and directors of BEKE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Zhu HansongDirector | Tax | 803 | $17.73 | $14k | Sep 3, 2026 |
| Chen XiaohongDirector | Tax | 1 | $17.73 | $18 | Sep 3, 2026 |
| Zhu HansongDirector | GrantRestricted Share Units | 4.6k | — | — | Sep 2, 2026 |
| Zhu HansongDirector | ExerciseRestricted Share Units | 3.8k | — | — | Sep 2, 2026 |
| Zhu HansongDirector | Exercise | 3.8k | — | — | Sep 2, 2026 |
| Chen XiaohongDirector | GrantRestricted Share Units | 10.7k | — | — | Sep 2, 2026 |
| Chen XiaohongDirector | ExerciseRestricted Share Units | 8.8k | — | — | Sep 2, 2026 |
| Chen XiaohongDirector | Exercise | 8.8k | — | — | Sep 2, 2026 |
| WU JUNDirector | Other | 3.9k | — | — | Mar 26, 2026 |
No analyst notes on BEKE yet.
Analyst Ratings
21 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 7 | 15 | 1 | 0 | 0 | Buy1.74 |
| 1 mo ago | 6 | 14 | 1 | 0 | 0 | Buy1.76 |
| 2 mo ago | 6 | 14 | 1 | 0 | 0 | Buy1.76 |